ISOLATION AND CHARACTERIZATION OF PEPTIDES FROM MILK AS NATURAL INHIBITORS OF ACE I AND FOOD ADDITIVES

Q3 Engineering
B. Yakimova, Ralitza Alexova, Lili Dobreva, Yuliana Rainova, Stefan Dobrev, Svetla Danova, Silvia Angelova, I. Stoineva
{"title":"ISOLATION AND CHARACTERIZATION OF PEPTIDES FROM MILK AS NATURAL INHIBITORS OF ACE I AND FOOD ADDITIVES","authors":"B. Yakimova, Ralitza Alexova, Lili Dobreva, Yuliana Rainova, Stefan Dobrev, Svetla Danova, Silvia Angelova, I. Stoineva","doi":"10.59957/jctm.v59.i4.2024.5","DOIUrl":null,"url":null,"abstract":"Inhibition of Angiotensin-converting enzyme I (ACE I) is a modern therapeutic approach to treatment of hypertension. In recent years, research into natural ACE peptide inhibitors without side effects has become important.The aim of this study is to isolate and characterize novel bioactive peptides from skim and/or whole cow’s milk fermented with selected lactobacillus strains. Several homo/heterofermentative strains of the Lactobacillus species of dairy origin have been pre-selected and different milk fermented samples have been studied. A protocol for analyses was designed and the milk proteins were separated by centrifugation at 4°C at 10000 × g, with molecular mass cut off (MWCO) membranes of 3 and 10 kDa. The samples with molecular mass below 3 kDa were further separated by ultrafiltration by dialysis cell (cut off membrane 1 kDa) by continuous stirring at room temperature. The milk fractions under 1 kDa molecular mass were characterized by UPLC-MS. The ACE-inhibitory activity was determined using the FAPGG (N-[3-(2-Furyl) acryloyl]-L-phenylalanyl-glycyl-glycine) degradation method. All tested samples (1 kDa) exhibit ACE I inhibitory activity with IC50 in a range of 6 - 37 mg mL-1. In silico logP prediction of selected peptides was used to assess whether lipophilicity of the compounds falls within the so-called “therapeutically relevant pharmacokinetic space”.","PeriodicalId":38363,"journal":{"name":"Journal of Chemical Technology and Metallurgy","volume":" 45","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Chemical Technology and Metallurgy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59957/jctm.v59.i4.2024.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0

Abstract

Inhibition of Angiotensin-converting enzyme I (ACE I) is a modern therapeutic approach to treatment of hypertension. In recent years, research into natural ACE peptide inhibitors without side effects has become important.The aim of this study is to isolate and characterize novel bioactive peptides from skim and/or whole cow’s milk fermented with selected lactobacillus strains. Several homo/heterofermentative strains of the Lactobacillus species of dairy origin have been pre-selected and different milk fermented samples have been studied. A protocol for analyses was designed and the milk proteins were separated by centrifugation at 4°C at 10000 × g, with molecular mass cut off (MWCO) membranes of 3 and 10 kDa. The samples with molecular mass below 3 kDa were further separated by ultrafiltration by dialysis cell (cut off membrane 1 kDa) by continuous stirring at room temperature. The milk fractions under 1 kDa molecular mass were characterized by UPLC-MS. The ACE-inhibitory activity was determined using the FAPGG (N-[3-(2-Furyl) acryloyl]-L-phenylalanyl-glycyl-glycine) degradation method. All tested samples (1 kDa) exhibit ACE I inhibitory activity with IC50 in a range of 6 - 37 mg mL-1. In silico logP prediction of selected peptides was used to assess whether lipophilicity of the compounds falls within the so-called “therapeutically relevant pharmacokinetic space”.
从牛奶中分离肽并确定其特性,将其作为 Ace I 天然抑制剂和食品添加剂
抑制血管紧张素转换酶 I(ACE I)是现代治疗高血压的一种方法。本研究的目的是从脱脂奶和/或用精选乳酸杆菌菌株发酵的全脂牛奶中分离和鉴定新型生物活性肽。我们预先选择了几种乳制品来源的乳酸杆菌同种/异种发酵菌株,并对不同的牛奶发酵样品进行了研究。我们设计了一套分析方案,在 4°C 温度下以 10000 × g 离心,用分子质量截断 (MWCO) 为 3 kDa 和 10 kDa 的膜分离牛奶蛋白质。分子质量低于 3 kDa 的样品在室温下持续搅拌,通过透析池(截留膜 1 kDa)超滤进一步分离。分子质量在 1 kDa 以下的牛奶馏分采用 UPLC-MS 进行表征。采用 FAPGG(N-[3-(2-呋喃基)丙烯酰基]-L-苯丙氨酰-甘氨酰-甘氨酸)降解法测定 ACE 抑制活性。所有测试样品(1 kDa)都具有 ACE I 抑制活性,IC50 在 6 - 37 mg mL-1 之间。对所选肽段的 logP 进行了硅预测,以评估化合物的亲脂性是否属于所谓的 "治疗相关药代动力学空间"。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Chemical Technology and Metallurgy
Journal of Chemical Technology and Metallurgy Engineering-Industrial and Manufacturing Engineering
CiteScore
1.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信